- Atlas’ $400M growth fund will support its portfolio of biotechs FirstWord Pharma
- Atlas Venture Announces $400 Million Third Opportunity Fund Business Wire
- VC Atlas lands $400M to support existing biotech portfolio Fierce Biotech
- Biotech VC raises $400 million ‘opportunity’ fund in sign of possible industry rebound statnews.com
- Atlas Venture reels in $400M to grow its biotech startups BioPharma Dive
The wire
More investor news
MTN expects Nigeria rebound as airtime lending resumes – TechCabal
84 M&A deals worth $11.4 billion in disclosed value recorded so far in 2026 – TechCabal
Valor, Point72 back General Intuition at $6B valuation as AI startup pushes into robotics – TechCrunch Venture
Africa’s data sovereignty push is reshaping the AI race, and AWS wants in – TechCabal
Hugging Face reportedly in talks to be acquired for $13B – TechCrunch Venture
COPD diagnosis is broken. TidalSense wants to fix it with 75 seconds of breathing – Tech.eu